With up to 14% weight loss over 48 weeks in Phase 3 trials and a favorable safety profile, it may represent an effective treatment option for adolescents, particularly those with lipid-driven metabolic disturbances
Pi-Sunyer X et al (2015) A randomized, controlled trial of 3.0 mg of liraglutide in weight management
Conversely, certain GLP-1 receptor agonists, such as exenatide, have shown neuroprotective effects in clinical trials, indicating the potential for cross-therapeutic benefits (Troshneva and Ametov, 2022)
However, Zepbound savings programs offer eligible individuals with commercial insurance copays as low as $25/month, while single dose vials are available for $299-$449 through LillyDirect
To view a copy of this licence, visit About this article Cite this article Wei, Q., Zhao, J
Oatp2 mediates bidirectional organic solute transport: a role for intracellular glutathione